This website is intended for healthcare professionals

Helen Mitchell

Breast Nurse Clinician, The Christie NHS Foundation Trust, Manchester

Email Helen

Intravenous versus subcutaneous trastuzumab: an economic and patient perspective

Until December 2013, trastuzumab, licensed for the treatment of patients with Her2-positive early or metastatic breast cancer, was available as a powder for reconstitution before intravenous...

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP